Akums Drugs & Pharmaceuticals Ltd (AKUMS) — Announcement | 16 September 2026
Akums Drugs & Pharmaceuticals announced its participation in a scheduled investor and analyst meet on September 22, 2026, at 10:00 AM IST, including a G200 Summit group session at Taj, Santacruz, Mumbai, with no unpublished price-sensitive information to be shared.
About Akums Drugs & Pharmaceuticals Ltd (AKUMS)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when AKUMS files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track AKUMS — Free💡 Ask AI about this filing
Ask AI Free →📊 More AKUMS filings
- Announcement — 25 September 2026Akums Drugs & Pharmaceuticals announced that its insider trading compliance window closes on October...
- 🔴 Announcement — 23 September 2026Akums Drugs & Pharmaceuticals announced its schedule for two institutional investor meetings on Sept...
- 🔴 Announcement — 3 September 2026Akums Drugs & Pharmaceuticals announced it received an ESG rating of 65 from NSE Sustainability for ...
- Announcement — 25 August 2026Akums Drugs and Pharmaceuticals announced its participation in scheduled investor and analyst meetin...
- Announcement — 24 August 2026Akums Drugs and Pharmaceuticals announced that its management cannot attend the scheduled Antique St...
🔥 Also filed on 16 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when AKUMS files new disclosures
Track AKUMS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AKUMS — FreeFree account · 2 AI queries/day